SCHEMBL1600528

SCHEMBL1600528

O=C(NCCC1CC1)c1ccc(N2CCN(Cc3ccccc3C(F)(F)F)CC2)nn1

nearest known ligand 0.76

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
SCD O00767 12/20 0.71
DCTPP1 Q9H773 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1377497 0.88 SCD (0.73) SCD
SCHEMBL1379993 0.88 SCD (0.73) SCD
SCHEMBL1817527 0.88 SCD (0.70) SCDDCTPP1
SCHEMBL1377064 0.88 SCD (0.73) SCD
SCHEMBL1379336 0.87 SCD (0.75) SCDDCTPP1
SCHEMBL27776422 0.86 SCD (0.72) SCDDCTPP1
SCHEMBL2474582 0.85 SCD (0.52) SCD
SCHEMBL1378991 0.83 SCD (1.00) SCDDCTPP1
SCHEMBL1813574 0.83 SCD (0.71) SCDDCTPP1
SCHEMBL1380584 0.83 SCD (0.66) SCD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1648874-B1 PIPERAZINE DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS XENON PHARMACEUTICALS INC (CA) 2011-10-05 EP claimed
EP-1846035-B1 COMBINATION THERAPY XENON PHARMACEUTICALS INC (CA) 2011-09-21 EP claimed
EP-1846035-B1 COMBINATION THERAPY XENON PHARMACEUTICALS INC (CA) 2011-09-21 EP disclosed
US-7919484-B2 Combination therapy XENON PHARMACEUTICALS INC. (CA) 2011-04-05 US disclosed